BANZEL

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug BANZEL contains one active pharmaceutical ingredient (API):

1	Rufinamide UNII WFW942PR79 - RUFINAMIDE
	Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state.
	Read more about Rufinamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BANZEL Film-coated tablet / Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AF03	Rufinamide	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02369613, 02369621, 02369648
US	FDA, National Drug Code	62856-582, 62856-583, 62856-584